Kidswell Bio (TSE:4584) Other Long-Term Liabilities: 円40 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4584 Kidswell Bio Corp TSE:4584
44 GF Score
Price 円163.00
GF Value 円234.41
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Kidswell Bio Other Long-Term Liabilities?

Kidswell Bio TSE:4584 -1.81% 44 Other Long-Term Liabilities is 円40 Mil as of Mar. 2026. GuruFocus rates TSE:4584 with a GF Score™ of 44/100 and a GF Value™ of 円234.41 (Possible Value Trap). The stock has 6 warning signs investors should review.

Kidswell Bio's other long-term liabilities for the quarter that ended in Mar. 2026 was 円40 Mil.

Kidswell Bio's quarterly other long-term liabilities declined from Sep. 2025 (円70 Mil) to Dec. 2025 (円42 Mil) and declined from Dec. 2025 (円42 Mil) to Mar. 2026 (円40 Mil).

Kidswell Bio's annual other long-term liabilities increased from Mar. 2024 (円-0 Mil) to Mar. 2025 (円56 Mil) but then declined from Mar. 2025 (円56 Mil) to Mar. 2026 (円40 Mil).

Kidswell Bio Other Long-Term Liabilities Related Terms

Kidswell Bio Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Kidswell Bio's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kidswell Bio Other Long-Term Liabilities Chart

Kidswell Bio Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.00 56.36 39.53

Kidswell Bio Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 73.93 69.54 42.24 39.53 38.36
TSE:4584
44GF Score
Kidswell Bio Corp TSE:4584
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kidswell Bio Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of 円40 Mil mean?
Kidswell Bio (TSE:4584) has a Other Long-Term Liabilities of 円40 Mil as of Mar. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Kidswell Bio and its competitors.
Is Kidswell Bio's Other Long-Term Liabilities too high?
Kidswell Bio's current Other Long-Term Liabilities is 円40 Mil. Overall, Kidswell Bio has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kidswell Bio's Other Long-Term Liabilities compare to VRTX and REGN?
Kidswell Bio's Other Long-Term Liabilities of 円40 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Biotechnology company?
A good Other Long-Term Liabilities depends on the Biotechnology industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Kidswell Bio and its competitors. Kidswell Bio's current Other Long-Term Liabilities is 円40 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kidswell Bio stock overvalued right now?
Based on GuruFocus' analysis, Kidswell Bio (TSE:4584) is currently considered Possible Value Trap. The stock's GF Value™ is 円234.41, compared to a current price of 円163.00 — trading 30.5% below its estimated fair value. The current Other Long-Term Liabilities is 円40 Mil. Kidswell Bio's overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Kidswell Bio (TSE:4584), the current Other Long-Term Liabilities is 円40 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kidswell Bio (TSE:4584) Overvalued in 2026?

Based on GuruFocus' analysis, Kidswell Bio stock appears to be undervalued. The current stock price of 円163.00 is trading 30.5% below its estimated GF Value™ of 円234.41. GuruFocus considers Kidswell Bio to be Possible Value Trap.

Key valuation signals for TSE:4584:

  • Other Long-Term Liabilities: 円40 Mil
  • GF Value™: 円234.41 vs. price of 円163.00 (30.5% below fair value)
  • GF Score™: 44/100 with 6 warning signs

No single metric tells the full story. See the TSE:4584 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kidswell Bio Business Description

Address 1-2-12, Shinkawa, Kanayama Building, 3rd Floor, Chuo-ku, Tokyo, JPN, 104-0033
Kidswell Bio Corp is a biopharmaceutical company engaged in the discovery and development of drugs.
44GF Score

Get the complete analysis for TSE:4584

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円163.00
Price
円234.41
GF Value